Pharmacy Drugs
Recent Posts
- EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored IND For Fourth 6-month Open Label Extension Of PRX-03140 For Alzheimer’s Disease
- Miriam Hospital Researcher Receives More Than $12 Million To Study Weight Control
- Novel HIV Drug To Be Studied In Cell Cultures And Patients
- ISCTM Meeting Discusses Clinical And Regulatory Aspects Of Using Adaptive Designs In Clinical Trials For Central Nervous System Drug Approvals
- Evaluation Of The Cost Effectiveness Of Implantable Blood Pressure Device
Random Posts
- Millennium Initiates Phase II Trial For Diffuse Large B-Cell Lymphoma
- E-Cigarettes Subject of FDA Warning
- Patients Say Costs Determining Factor In Their Treatment Decisions
- Comparing Two Surgical Strategies For Infant Heart Defect
- Amarillo Biosciences Announces Completion Of Screening Process For Influenza Study In Australia
- DayQuil Packs Recalled for Lack of Childproofing
- Novel Peripheral IV Catheter: Telesso Technologies Wins Popular Science Invention Award
- Promedior Initiates Phase 1 Clinical Trial Of PRM-151, A Novel Compound For The Treatment Of Fibrotic Diseases And Tissue Remodeling
- Ardea Biosciences Announces Positive Interim Phase 2a Results For Lead Gout Drug, RDEA594
- Human Trials Commence Next Year For The First Genetically-Engineered Malaria Vaccine
Society Welcomes ‘Yes’ Vote To Charter Changes
Posted by: admin in Pharmacy Drugs on July 26th, 2009
The Royal Pharmaceutical Society of Great Britain pledged to continue to build a
professional leadership body fit for the 21st century after members voted to accept the changes
to the Society’s Royal Charter in the Special Resolution Ballot.
The ballot was the highest turnout achieved in recent years, with 10,698 votes cast in total,
equating to a 22.3% voter turnout. Of those voting, 77.7% of members agreed to accept the
Charter changes.
President Steve Churton said “I’m delighted that members have shown overwhelming
confidence in the new body and made their commitment to the future of the profession.
“We now have the strong mandate from members for the changes we need to bring about.
Changes that members have asked for through the Clarke Inquiry, the Transitional Committee
and the Charter consultation process. We will be doing this with the continued engagement of
a wide range of professional groups within pharmacy and the active involvement of over 200
pioneers who have agreed to help us with the design of the new body’s products and services.
“The new body will see greater autonomy for the National Pharmacy Boards, which will be able
to influence and respond to devolved healthcare policy more effectively than at present, and
ensure close engagement with the needs and aspirations of the membership in England,
Scotland and Wales.
“It is anticipated that the Charter changes will be brought into force when the Society’s current
regulatory functions transfer to the new General Pharmaceutical Council (GPhC) in 2010.
“I urge as many pharmacists as possible to get involved in the process of building our new
leadership body and help shape the future of the profession. We have a unique opportunity to
create a vibrant and dynamic new organisation that will provide essential support for
pharmacists, become a badge of true professionalism and make a lasting difference to the
lives of pharmacists and their patients.”
Notes
Number of eligible voters: 48,115
Votes cast by post: 6,966
Votes cast online: 2,573
Votes cast by text: 564
Votes cast by telephone: 603
Total number of votes cast: 10,706
Turnout: 22.3%
Number of votes found to be invalid: 8
Total number of valid votes to be counted: 10,698
Result:
Number voting Yes: 8,309 (77.7% of the valid vote)
Number voting No: 2,389 (22.3% of the valid vote)
Total 10,698 (100% of the valid vote)
All data supplied by Electoral Reform Services
Next steps:
- The result will be presented to the next Society Council meeting on Wednesday 29th July.
- The changes will then be submitted to the Privy Council. The Privy Council determine their
own timetable, but it is hoped that approval for the changes will be given by the end of
2009.
- The Charter changes will come into being when regulation transfers to General
Pharmaceutical Council in April 2010.
Source
Royal Pharmaceutical Society of Great Britain